Literature DB >> 15941721

Determination of the functionality of common APOA5 polymorphisms.

Philippa J Talmud1, Jutta Palmen, Wendy Putt, Laurence Lins, Steve E Humphries.   

Abstract

Common variants of APOA5 have consistently shown association with differences in plasma triglyceride (TG) levels. These single nucleotide polymorphisms (SNPs) fall into three common haplotypes: APOA5*1, with common alleles at all sites; APOA5*2, with rare alleles of -1131T--> C, -3A--> G, 751G--> T, and 1891T--> C; and APOA5*3, distinguished by the c56C--> G (S19W). Molecular modeling of the apoAV signal peptide (SP) showed an increased angle of insertion (65 degrees ) at the lipid/water interface of Trp-19 SP compared with Ser-19 SP (40 degrees ), predicting reduced translocation. This was confirmed by 50% reduction of Trp-19-encoded SP.secretory alkaline phosphatase (SEAP) fusion protein secreted into the medium from HepG2 cells compared with the Ser-19.SEAP fusion protein (p < 0.002). Considering APOA5*2 SNPs, there was no significant difference in the relative luciferase expression in Huh7 cells transiently transfected with a -1131T construct compared with the -1131C (fragments -1177 to -516 or -1177 to -3). Similarly, for the -3A--> G in the Kozak sequence, in vitro transcription/translation assays and primer extension inhibition assays showed no alternate AUG initiation codon usage, demonstrating that -3A--> G did not influence translation efficiency. Although 1891T--> C in the 3'-untranslated region disrupts a putative Oct-1 transcription factor binding site, when inserted 3' of the luciferase gene the T--> C change demonstrated no significant difference in luciferase expression. Thus, association of APOA5*2 SNPs with TG levels is not due to the individual effects of any of these SNPs, although cooperativity between the SNPs cannot be excluded. Alternatively, the effect on TG levels may reflect the strong linkage disequilibrium with the functional APOC3 SNPs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15941721     DOI: 10.1074/jbc.M502144200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.

Authors:  G M Dallinga-Thie; A van Tol; H Hattori; L C van Vark-van der Zee; H Jansen; E J G Sijbrands
Journal:  Diabetologia       Date:  2006-04-28       Impact factor: 10.122

Review 2.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

3.  An APOA5 3' UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding site.

Authors:  Cyrielle Caussy; Sybil Charrière; Christophe Marçais; Mathilde Di Filippo; Agnès Sassolas; Mireille Delay; Vanessa Euthine; Audrey Jalabert; Etienne Lefai; Sophie Rome; Philippe Moulin
Journal:  Am J Hum Genet       Date:  2014-01-02       Impact factor: 11.025

4.  Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers.

Authors:  Qin Feng; Susan S Baker; Wensheng Liu; Ricardo A Arbizu; Ghanim Aljomah; Maan Khatib; Colleen A Nugent; Robert D Baker; Trudy M Forte; Yiyang Hu; Lixin Zhu
Journal:  Pathology       Date:  2015-06       Impact factor: 5.306

Review 5.  Genetic determinants of plasma triglycerides.

Authors:  Christopher T Johansen; Sekar Kathiresan; Robert A Hegele
Journal:  J Lipid Res       Date:  2010-11-01       Impact factor: 5.922

Review 6.  Update on APOA5 Genetics: Toward a Better Understanding of Its Physiological Impact.

Authors:  Montse Guardiola; Josep Ribalta
Journal:  Curr Atheroscler Rep       Date:  2017-07       Impact factor: 5.113

7.  The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.

Authors:  P J Talmud; J A Cooper; H Hattori; I P Miller; G J Miller; S E Humphries
Journal:  Diabetologia       Date:  2006-08-18       Impact factor: 10.122

8.  Intracellular lipid droplet targeting by apolipoprotein A-V requires the carboxyl-terminal segment.

Authors:  Xiao Shu; Robert O Ryan; Trudy M Forte
Journal:  J Lipid Res       Date:  2008-04-30       Impact factor: 5.922

9.  Gene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndrome.

Authors:  Paula Singmann; Jens Baumert; Christian Herder; Christa Meisinger; Christina Holzapfel; Norman Klopp; H-Erich Wichmann; Martin Klingenspor; Wolfgang Rathmann; Thomas Illig; Harald Grallert
Journal:  Obes Facts       Date:  2009-07-20       Impact factor: 3.942

10.  The ins (cell) and outs (plasma) of apolipoprotein A-V.

Authors:  Trudy M Forte; Xiao Shu; Robert O Ryan
Journal:  J Lipid Res       Date:  2008-12-02       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.